Press
Successful exit for High-Tech Gründerfonds and Evonik Venture Capital – Synoste Oy becomes part of Globus Medical
Globus Medical, based in Audubon, Pennsylvania, USA, is a leading medical device manufacturerThe Finnish start-up Synoste, with offices in Helsinki and Düsseldorf, develops high-tech implants for minimally invasive treatment of leg length discrepancyThe transaction marks HTGF’s 11th successful exit during the coronavirus crisis
High-Tech Gründerfonds (HTGF) and Evonik Venture Capital have exited Finnish start-up Synoste Oy. US based Globus Medical (NYSE: GMED) acquired all shares. Hig
Press
Successful exit for High-Tech Gründerfonds and Bayern Kapital –
Proteintech acquires ChromoTek
Proteintech, which is based in Chicago, Illinois, USA, is the benchmark in antibodiesMartinsried-based startup ChromoTek is a market leader in nanobodiesThe acquisition enables Proteintech to expand its next-generation antibody toolsBayern Kapital and HTGF arranged the seed financing in 2010The transaction marks HTGF’s 10th successful exit during the coronavirus crisis
High-Tech Gründerfonds and Bayern Kapital have sold their shares in ChromoTek after having spent 10 years at the start
Press
HTGF portfolio company: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment
European Investment Bank and Atriva Therapeutics sign financing agreement of €24 million for the research, development and clinical testing of the company’s lead product candidate against influenza and COVID-19Atriva’s ATR-002 molecule is the only host-cell targeting antiviral therapeutic specifically developed to treat severe respiratory infections caused by RNA (ribonucleic acid) viruses – it may prevent progression to critical-stage COVID-19 in hospitalised patients and holds stro
Blog
Pivoting to become the market leader
In this interview, Ralf Rottmann, Managing Director and founder of grandcentrix, and HTGF Partner Markus Kreßmann talk about how grandcentrix made a radical departure from its original business idea to become a leading IoT solutions provider – and why HTGF was the only conceivable investor for the team of founders.
Markus, HTGF was the sole investor in grandcentrix. The exit took place just under a year ago, in November 2019, when Vodafone completed a takeover of the company, which
Press
btov Partners, HV Holtzbrinck Ventures and HTGF invest in Real World Evidence and Patient-Reported Outcomes: 5 million euros for heartbeat medical
New standards for care management are set by connecting and utilising clinical data alongside data tracking patient-provided perspectives on their health status over timeFundamental trend in health care: Patient-Reported Outcome Measures (PROMS) and Real World Evidence (RWE)Over 200 hospital teams, registries and research institutions have registered to use the platform registered as a CE-marked medical device
The digital health start-up heartbeat medical has closed a Series A financing r
Press
Neuromodulation pioneer WISE closes EUR 15M Series C financing round
to launch second product, SCS EXPERT, for chronic pain
SCS EXPERT – first expandable percutaneous lead for neuromodulation treatment of chronic painNew investors, CDP Venture Capital and Eureka!, join existing participating investors in financing roundAdds to EUR 2.3M grant earlier in 2020 from the European Commission to launch SCS EXPERT
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the closing of a EUR 15 million Serie
Press
Grandperspective GmbH secures seed financing
Making gas leaks in the chemical industry visible from kilometres away
Over 30% of major leaks of toxic of flammable industrial gases remain undetected by gas sensors. Grandperspective develops with the scanfeldTM world’s first early warning solution monitoring entire chemical parks for gas leaks. The High-Tech Gründerfond (HTGF) finances this innovation in cooperation with Brandburg Kapital, DiaMedCare and various business angels.
The scanfeldTM early warning solution combines
Press
Successful Exit for High-Tech Gründerfonds – Zoovu and SEMKNOX Merger
Zoovu, is the global leader in Conversational SearchThe Startup SEMKNOX, based in Dresden, perfectly complements the core business of ZoovuSeed investors WestTech Ventures and High-Tech Gründerfonds (HTGF) as well as business angels Tobias Kroha and Dr. David Monbaron sell their sharesFor the HTGF it is the 9th successful exit during the Corona crisis
The High-Tech Gründerfonds sold its shares in SEMKNOX after accompanying the company for the past 5 years. Zoovu Boston, USA, is provider
Press
Betterfront completes seed financing from HTGF to bring private equity fund raising to the next level
Private equity fund managers can say goodbye to the madness of the capital-raising process thanks to Betterfront’s data-driven fundraising platform. The company provides fund managers with a fundraising and data analytics platform, which generates insights that drive allocators’ investment decisions. High-Tech Gründerfonds led the seed round and was joined by a group of angel investors.
Betterfront closed an oversubscribed seed round. HTGF led the financing with the participation of
Press
Successful Exit for High-Tech Gründerfonds – Intersect ENT acquires Fiagon
Buyer is the Intersect ENT, a medical technology company based in the USThe startup Fiagon AG Medical Technologies expands Intersects portfolio of ENT product offeringsFor the HTGF it is the 8th successful exit during the Corona crisis
The High-Tech Gründerfonds sold its shares in Fiagon. The seed investor has accompanied the company for 11 years. The publicly traded company Intersect ENT (NASDAQ: XENT), Menlo Park, California, USA, is dedicated to transforming the treatment of ear
Blog
“HTGF plays a valuable role that goes beyond seed financing”
High-Tech Gründerfonds (HTGF) is celebrating its 15-year anniversary. Professor Dieter Jahn, who spent many years heading up BASF Group’s Science Relations and Innovation Management competence centre, was one of the initiators and driving forces behind the seed-stage investor back in 2005. Since day one, Jahn has been at HTGF’s side as a member of its advisory board. In an interview, he talks about how it all began, underlines HTGF’s importance as a driver of innovation, and explains
Blog
15 years HTGF: 15 facts & figures
Our operational business started on September 1st, 15 years ago. To celebrate this, over the past 15 days we have shared facts, figures and little insights about the last few years via social media. To kick off, we celebrated our 591 closings to date and close the 15 days today with 114 exits in 15 years! The exciting postings of the last 15 days are summarized here in this graphic. Have fun discovering fun facts!
The facts and figures presented are based on the reporting date. R
Blog
“HTGF plays a valuable role that goes beyond seed financing”
Professor Dieter Jahn, who spent many years heading up BASF Group’s Science Relations and Innovation Management competence centre, was one of the initiators and driving forces behind High-Tech Gründerfonds back in 2005. Since day one, Jahn has been at HTGF’s side as a member of its advisory board. In an interview, he talks about how it all began, underlines HTGF’s importance as a driver of innovation, and explains how HTGF can provide important stimulus both now and in the future.
Press
Educate machines to read: Deep-Tech Startup Natif.ai secures seed financing
The Saarbrücken-based Deep-Tech Startup Natif.ai announces the successful closing of a seven-digit financing round with the lead investor High-Tech Gründerfonds (HTGF). Thanks to revolutionary AI models and a self-developed Deep-OCR, various documents can be analyzed extremely quickly, accurately and relevant data can be extracted. Natif.ai thus enables a fast and efficient way to productively bring artificial intelligence into the economy. With this financing, the founding team is investi
Press
bookingkit receives Millions in additional Strategic Investment Capital
bookingkit, Europe’s leading Software-as-a-Service company for providers of tours, attractions and activities, emerges strengthened from the Covid-19 crisis: The industry-wide dip in tourism-related revenue after the Europe-wide contact restrictions in spring is now facing a strongly accelerated sales development. In order to make strategic use of this momentum and further expand its position in various European markets, the Berlin-based company is receiving additional capital in the m